Nintedanib-loaded exosomes from adipose-derived stem cells inhibit pulmonary fibrosis induced by bleomycin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nintedanib-loaded exosomes from adipose-derived stem cells inhibit pulmonary fibrosis induced by bleomycin

Published:2024-01-20 Issue:6 Volume:95 Page:1543-1552
ISSN:0031-3998
Container-title:Pediatric Research
language:en
Short-container-title:Pediatr Res

Author:

Cai Liyun,Wang Jie,Yi Xue,Yu Shuwei,Wang Chong,Zhang Liyuan,Zhang Xiaoling,Cheng Lixian,Ruan Wenwen,Dong Feige,Su Ping,Shi Ying

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41390-024-03024-7.pdf

Reference51 articles.

1. Richeldi, L., Collard, H. & Jones, M. Idiopathic pulmonary fibrosis. Lancet 389, 1941–1952 (2017).

2. Wynn, T. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199–210 (2008).

3. Wynn, T. & Ramalingam, T. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028–1040 (2012).

4. Hutchinson, J., Fogarty, A., Hubbard, R. & McKeever, T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur. Respir. J. 46, 795–806 (2015).

5. Somogyi, V. et al. The therapy of idiopathic pulmonary fibrosis: what is next? Eur. Respir. Rev. 28, 190021 (2019).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential therapeutic effect of human umbilical cord mesenchymal stem cell-derived exosomes in bronchopulmonary dysplasia;Life Sciences;2024-09

2. Different origin-derived exosomes and their clinical advantages in cancer therapy;Frontiers in Immunology;2024-06-27

3. Molecular Mechanisms Responsible for the Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Lung Fibrosis;International Journal of Molecular Sciences;2024-04-16

4. Mesenchymal stromal cell-based therapy in lung diseases; from research to clinic;American Journal of Stem Cells;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3